International Continence Society best practice statement for use of sacral neuromodulation. Issue 5 (11th April 2018)

• Record Type: Journal Article
• Authors: Goldman, Howard B.; Lloyd, Jessica C.; Noblett, Karen L.; Carey, Marcus P.; Castaño Botero, Juan Carlos; Gajewski, Jerzy B.; Lehur, Paul A.; Hassouna, Magdy M.; Matzel, Klaus E.; Paquette, Ian M.; de Wachter, Stefan; Ehlert, Michael J.; Chartier‐Kastler, Emmanuel; Siegel, Steven W.
• Is Part Of: Neurourology and urodynamics. Volume 37:Issue 5(2018:Jun.)
• Page Start: 1823
• Page End: 1848
• Publication Date: 2018-04-11
• Subjects: best practices -- fecal incontinence -- overactive bladder -- sacral nerve stimulation -- sacral neuromodulation; Urinary organs -- Periodicals; Urodynamics -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1002/nau.23515
• Languages: English
• ISSNs: 0733-2467

Abstract

Abstract : Aims: Sacral neuromodulation (SNM) is an accepted therapy for a variety of conditions. However, despite over 20 years of experience, it remains a specialized procedure with a number of subtleties. Here we present the recommendations issued from the International Continence Society (ICS) SNM Consensus Panel. Methods: Under the auspices of the ICS, eight urologists, three colorectal surgeons and two urogynecologists, covering a wide breadth of geographic and specialty interest representation, met in January 2017 to discuss best practices for neuromodulation. Suggestions for statements were submitted in advance and specific topics were assigned to committee members, who prepared and presented supporting data to the group, at which time each topic was discussed in depth. Best practice statements were formulated based on available data. This document was then circulated to multiple external reviewers after which final edits were made and approved by the group. Results: The present recommendations, based on the most relevant data available in the literature, as well as expert opinion, address a variety of specific and at times problematic issues associated with SNM. These include the use of SNM for a variety of underlying conditions, need for pre‐procedural testing, use of staged versus single‐stage procedures, screening for success during the trial phase, ideal anesthesia, device implantation, post‐procedural management, trouble‐shooting loss of device function, and future directions for research. Conclusions: These guidelines undoubtedly constitute a reference document, which will help urologists, gynecologists, and colorectal surgeons optimize their use of SNM for refractory urinary urgency and frequency, UUI, NOR, and FI.